CIS
AZN icon

Capital International Sarl’s AstraZeneca AZN Stock Holding History

Capital International Sarl’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178M Buy
+914,752
New +$176M 2.92% 6
2024
Q4 		– Sell
-22,304
Closed -$3.48M – 285
2024
Q3 		$3.48M Buy
22,304
+3,298
+17% +$532K 0.09% 147
2024
Q2 		$2.96M Sell
19,006
-139
-0.7% -$20.9K 0.09% 156
2024
Q1 		$2.59M Buy
19,145
+832
+5% +$110K 0.09% 168
2023
Q4 		$2.47M Buy
18,313
+1,840
+11% +$239K 0.09% 172
2023
Q3 		$2.23M Buy
16,473
+842
+5% +$115K 0.1% 164
2023
Q2 		$2.24M Buy
15,631
+2,103
+16% +$309K 0.1% 169
2023
Q1 		$1.88M Sell
13,528
-28,974
-68% -$3.9M 0.09% 184
2022
Q4 		$5.76M Buy
42,502
+3,273
+8% +$410K 0.41% 84
2022
Q3 		$4.3M Buy
39,229
+646
+2% +$82K 0.35% 89
2022
Q2 		$5.1M Buy
38,583
+6,326
+20% +$830K 0.41% 80
2022
Q1 		$4.28M Buy
32,257
+1,241
+4% +$149K 0.21% 126
2021
Q4 		$3.61M Buy
31,016
+4,588
+17% +$540K 0.17% 136
2021
Q3 		$3.17M Buy
26,428
+3,217
+14% +$374K 0.28% 100
2021
Q2 		$2.78M Buy
23,211
+7,602
+49% +$834K 0.24% 111
2021
Q1 		$1.55M Sell
15,609
-2,139
-12% -$215K 0.15% 137
2020
Q4 		$1.77M Sell
17,748
-1,931
-10% -$205K 0.19% 120
2020
Q3 		$2.16M Sell
19,679
-3,604
-15% -$401K 0.26% 97
2020
Q2 		$2.46M Sell
23,283
-27,192
-54% -$2.81M 0.33% 85
2020
Q1 		$4.51M Buy
50,475
+11,400
+29% +$1.07M 0.82% 41
2019
Q4 		$3.9M Hold
39,075
– – 0.6% 61
2019
Q3 		$3.48M Hold
39,075
– – 0.6% 55
2019
Q2 		$3.23M Sell
39,075
-200
-0.5% -$15.7K 0.45% 71
2019
Q1 		$3.18M Hold
39,275
– – 0.4% 79
2018
Q4 		$2.98M Sell
39,275
-11,100
-22% -$867K 0.36% 85
2018
Q3 		$3.99M Sell
50,375
-22,300
-31% -$1.69M 0.38% 82
2018
Q2 		$5.1M Hold
72,675
– – 0.52% 56
2018
Q1 		$5.08M Buy
72,675
+6,350
+10% +$440K 0.49% 60
2017
Q4 		$4.6M Buy
66,325
+13,000
+24% +$877K 0.43% 64
2017
Q3 		$3.61M Buy
53,325
+4,350
+9% +$275K 0.3% 84
2017
Q2 		$3.34M Buy
48,975
+3,350
+7% +$219K 0.29% 85
2017
Q1 		$2.84M Buy
45,625
+12,800
+39% +$745K 0.24% 93
2016
Q4 		$1.79M Hold
32,825
– – 0.16% 113
2016
Q3 		$2.16M Buy
32,825
+2,900
+10% +$190K 0.18% 108
2016
Q2 		$1.81M Buy
29,925
+1,825
+6% +$106K 0.15% 118
2016
Q1 		$1.58M Buy
28,100
+300
+1% +$18K 0.13% 117
2015
Q4 		$1.89M Buy
27,800
+3,000
+12% +$197K 0.16% 108
2015
Q3 		$1.58M Buy
24,800
+13,300
+116% +$875K 0.14% 103
2015
Q2 		$733K Buy
11,500
+1,800
+19% +$123K 0.05% 131
2015
Q1 		$664K Buy
+9,700
New +$674K 0.05% 129

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Capital International Sarl's AZN Position: Q1 2026 in Review

Capital International Sarl opened a new position in AstraZeneca (AZN) in Q1 2026: 914,752 shares worth $178M. The stake represents 2.92% of the portfolio and ranks #6 among its holdings. This is a return to the name: Capital International Sarl previously reported a position in AZN as recently as Q3 2024.

Capital International Sarl first reported a position in AZN in Q1 2015 and has held it in 40 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Capital International Sarl held 914,752 shares of AstraZeneca worth $178M as of Q1 2026.
  • AstraZeneca was a new Capital International Sarl position in Q1 2026.
  • AstraZeneca made up 2.92% of Capital International Sarl's portfolio in Q1 2026, its #6 holding.
  • Capital International Sarl first reported a position in AstraZeneca in Q1 2015 and has held it in 40 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Capital International Sarl's 13F filing for Q1 2026, filed 13 May 2026.